Recombinant Mutant Human TNF-Related Apoptosis-Inducing Ligand (Beijing Sunbio Biotech)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameRecombinant Mutant Human TNF-Related Apoptosis-Inducing Ligand (Beijing Sunbio Biotech)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionTNF-related apoptosis-inducing ligand receptors modulators
TargetsTNF-related apoptosis-inducing ligand receptors
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesBeijing Sunbio Biotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBeijing Sunbio Biotech
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A